<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Axonics Modulation Technologies, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Axonics Modulation Technologies, Inc.

    Axonics Modulation Technologies, Inc. (NASDAQ:AXNX) is a medical technology company focused on the design, development, and commercialization of innovative and minimally invasive sacral neuromodulation (“SNM”) solutions. SNM therapy is primarily used to treat patients with overactive bladder (“OAB”), fecal incontinence (“FI”) and urinary retention (“UR”). Axonics currently has marketing approvals in Europe, Canada, and Australia for OAB, FI, and UR. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $400,000,000
    • SIC CODE
      3841
    • NIN CODE
      ####
    • LEADERSHIP
      Raymond W. Cohen
    • FOUNDED
      2012
    • EMPLOYEES
      51-100
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Intersect ENT, Inc.

    Intersect ENT, Inc.

    Intersect ENT (NASDAQ: XENT) is a medical technology company dedicated to advancin...

    Intersect ENT (NASDAQ: XENT) is a medical techn...

    Filing Type:    PU
    Takeda Pharmaceutical Co., Ltd.

    Takeda Pharmaceutical Co., Ltd.

    Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) is a global, values-base...

    Takeda Pharmaceutical Company Limited (TSE:4502...

    Filing Type:    PU
    Bellicum Pharmaceuticals, Inc.

    Bellicum Pharmaceuticals, Inc.

    Bellicum Pharmaceuticals is a clinical-stage biopharmaceutical company focused on ...

    Bellicum Pharmaceuticals is a clinical-stage bi...

    Filing Type:    PU
    Adaptive Biotechnologies Corporation

    Adaptive Biotechnologies Corporation

    We are a commercial-stage biotech company focused on harnessing the inherent biolo...

    We are a commercial-stage biotech company focus...

    Filing Type:    PU
    Cytonics Corp

    Cytonics Corp

    Cytonics, founded in 2006, is a private research and development company focused o...

    Cytonics, founded in 2006, is a private researc...

    Amount Raised:    $3,300,000.00
    Fundraising Status:    EC
    Filing Type:    CF
    Bioanalytical Systems, Inc.

    Bioanalytical Systems, Inc.

    BASi provides drug discovery and development services and analytical instruments t...

    BASi provides drug discovery and development se...

    Filing Type:    PU
    Beyond Air, Inc.

    Beyond Air, Inc.

    Beyond Air Inc. is a clinical-stage medical device and biopharmaceutical company d...

    Beyond Air Inc. is a clinical-stage medical dev...

    Filing Type:    PU
    Medigus Ltd.

    Medigus Ltd.

    Medigus is a medical device company specializing in developing minimally invasive ...

    Medigus is a medical device company specializin...

    Filing Type:    PU
    Delee Corp

    Delee Corp

    At Delee we’re fundamentally changing not only the way cancer is detected but also...

    At Delee we’re fundamentally changing not only ...

    Amount Raised:    $492,503.00
    Fundraising Status:    EC
    Filing Type:    CF
    ©2026 National Investor Network. All Rights Reserved.